223 related articles for article (PubMed ID: 35164979)
1. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Shi P; Zhang J; Li X; Li W; Li H; Fu P
Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
Chen T; Qin S; Gu Y; Pan H; Bian D
Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
[TBL] [Abstract][Full Text] [Related]
4. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
5. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis.
Li C; Zhang L; Bu X; Chu G; Zhao X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2022 Apr; 54(4):463-473. PubMed ID: 35607965
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion, and contributes to rituximab resistance in diffuse large B-cell lymphoma.
Liu C; Zhao X; Wang Z; Zhang C; Zheng W; Zhu X; Zhang D; Gong T; Zhao H; Li F; Guan T; Guo X; Zhang H; Yu B
J Biol Chem; 2024 Mar; 300(3):105762. PubMed ID: 38367665
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanism of lncRNA NORAD on proliferation and invasion of ovarian cancer cells through miR-199a-3p.
Xu C; Zhu LX; Sun DM; Yao H; Han DX
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1672-1681. PubMed ID: 32141533
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
Geng Q; Li Z; Li X; Wu Y; Chen N
J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
[TBL] [Abstract][Full Text] [Related]
11. LncRNA TSIX aggravates spinal cord injury by regulating the PI3K/AKT pathway via the miR-532-3p/DDOST axis.
Dong J; Wei Z; Zhu Z
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23384. PubMed ID: 37155292
[TBL] [Abstract][Full Text] [Related]
12. [Impacts of LncRNA NORAD on the Proliferation, Apoptosis, and Chemosensitivity of Non-small Cell Lung Cancer Cells by Regulating ZNF217 through MiR-199a-3p].
Gao Y; Luo X; Liao P; Luo Y
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):479-486. PubMed ID: 37653011
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis.
Zhu Q; Li Y; Guo Y; Hu L; Xiao Z; Liu X; Wang J; Xu Q; Tong X
J Cell Mol Med; 2019 Nov; 23(11):7395-7405. PubMed ID: 31483572
[TBL] [Abstract][Full Text] [Related]
14. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
Huang Q; Xing S; Peng A; Yu Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NORAD regulates scar hypertrophy via miRNA-26a mediating the regulation of TGFβR1/2.
Qi J; Wu Y; Zhang H; Liu Y
Adv Clin Exp Med; 2021 Apr; 30(4):395-403. PubMed ID: 33857357
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma.
Li Q; Li B; Lu CL; Wang JY; Gao M; Gao W
Cancer Gene Ther; 2021 Sep; 28(9):1046-1057. PubMed ID: 33311569
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NORAD stimulates proliferation and migration of renal cancer via activating the miR-144-3p/MYCN axis.
Zhao W; Wang L; Xu F
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10426-10432. PubMed ID: 33155199
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma.
Tian M; Li Y; Zheng W; Liu QQ; Zhang XL; Liu JL; Zhang S; Sheng YX; Fan CB; Zhang WL
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2567-2576. PubMed ID: 33829443
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PVT1 facilitates DLBCL development via miR-34b-5p/Foxp1 pathway.
Tao S; Chen Y; Hu M; Xu L; Fu CB; Hao XB
Mol Cell Biochem; 2022 Mar; 477(3):951-963. PubMed ID: 35098439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
